| Autor: |
Samadhan A. Jagtap, S. Sundar, H.B. Shivakumar, V.P. Baliga, C.S. Bolmall, K. Latchoumibady |
| Rok vydání: |
2010 |
| Předmět: |
|
| Zdroj: |
Osteoarthritis and Cartilage. 18:S252 |
| ISSN: |
1063-4584 |
| DOI: |
10.1016/s1063-4584(10)60590-0 |
| Popis: |
Purpose: A new Diacerein Modified Release (MR) formulation has been developed in India. The present prospective, randomized, double blind, multicentric, comparative study was undertaken to evaluate efficacy, safety and tolerability of Diacerein MR 100mg and conventional Diacerein 50mg in 224 adult patients with Osteoarthritis(OA) of the Knee after approval by the respective institutional ethics committee. Methods: Patients fulfilling selection criteria were treated with Diacerein MR 100mg once daily or Diacerein 50mg twice daily for 8 weeks after obtaining their informed consent. The primary efficacy variables included Improvement in Western Ontario and McMasters (WOMAC) individual osteoarthritis (OA) indices and Composite Index (for pain, stiffness and physical function) and the Visual Analog Scale (VAS) scores (for pain) while the secondary variable included improvement in Patient’s and Physician’s Global Assessment of Arthritis. Results: Seven patients in Diacerein MR and 8 in Diacerein group were lost to follow up. Thus a total 105 patients in Diacerein MR 100mg group and 106 in Diacerein 50mg group were included in the analysis. Results indicated that there was a statistically significant(p |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect